GluSense For Profit
GluSense is developing a miniature implantable continuous glucose sensor. The sensor will be implanted under the skin and will transmit continuous glucose values to an external unit or smartphone for over a full year, significantly improving the quality of life of diabetes patients. Founded in 2007, the company is part of the rainbow medical innovation house.
Technology:
Biomarker panels
Headquarters:
Lod, HaMerkaz, Israel
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
2007
Number Of Exists:
N/A
Employee Number:
10-50
Industry:
P4 Medicine
Investor Type:
N/A